Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 27-Apr-23 6:01 PM View:  | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 2,500,000 | -- | -- | (100%) 2.5M to 0 | |
| 27-Apr-23 6:01 PM View: | Ramos Eleanor Chief Medical Officer | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 70,000 | -- | -- | (100%) 70.0K to 0 | |
| 28-Apr-23 4:18 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 15,567,500 | -- | -- | (100%) 15.57M to 0 | |
| 27-Apr-23 6:07 PM View: | Pisano Wayne Director | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 7,500 | -- | -- | (100%) 7.5K to 0 | |
| 27-Apr-23 6:06 PM View: | Palmer Ashleigh Director and CEO | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 2,570,050 | -- | -- | (100%) 2.57M to 0 | |
| 27-Apr-23 6:02 PM View: | Catlin Avery W Director | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 20,000 | -- | -- | (100%) 20.0K to 0 | |
| 27-Apr-23 6:01 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 27-Apr-23 | Disposition (change in control) | 73,000 | -- | -- | (3%) 2.57M to 2.5M | |
| 24-Apr-23 4:18 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 21-Apr-23 | Gift | 224,617 | -- | -- | (1%) 15.79M to 15.57M | |
| 24-Apr-23 4:18 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 20-Apr-23 | Gift | 202,314 | -- | -- | (1%) 15.99M to 15.79M | |
| 18-Apr-23 8:57 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 14-Apr-23 | Sale | 2,190,550 | $24.32 | $53,274,200.00 | (12%) 18.18M to 15.99M | |
| 18-Apr-23 8:57 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 14-Apr-23 | Exercise (in-the money or at-the-money) | 8,879,020 | $6.00 | $53,274,100.00 | 95% 9.31M to 18.18M | |
| 14-Apr-23 5:24 PM View: | Catlin Avery W Director | Provention Bio, Inc. (PRVB) | 13-Apr-23 | Gift | 10,000 | -- | -- | 50% 20.0K to 30.0K | |
| 14-Apr-23 6:10 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 13-Apr-23 | Gift | 1,500,000 | -- | -- | 1027% 146.0K to 1.65M | |
| 14-Apr-23 5:24 PM View: | Catlin Avery W Director | Provention Bio, Inc. (PRVB) | 13-Apr-23 | Gift | 10,000 | -- | -- | (33%) 30.0K to 20.0K | |
| 14-Apr-23 6:10 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 13-Apr-23 | Gift | 1,500,000 | -- | -- | (91%) 1.65M to 146.0K | |
| 04-Apr-23 8:10 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 04-Apr-23 | Gift | 218,651 | -- | -- | (2%) 9.52M to 9.31M | |
| 04-Apr-23 8:10 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 31-Mar-23 | Disposition (other) | 3,000,000 | -- | -- | (24%) 12.52M to 9.52M | |
| 14-Feb-23 7:19 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 13-Feb-23 | Planned Option Sale | 25,985 | $10.04 | $260,944.00 | (< 1%) 2.6M to 2.57M | |
| 14-Feb-23 7:13 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 13-Feb-23 | Option Exercise | 25,835 | $2.50 | $64,587.50 | 1% 2.57M to 2.6M | |
| 14-Feb-23 7:13 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 13-Feb-23 | Planned Option Sale | 25,835 | $10.04 | $259,448.00 | (< 1%) 2.6M to 2.57M | |
| 14-Feb-23 7:19 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 13-Feb-23 | Option Exercise | 25,985 | $2.50 | $64,962.50 | 1% 2.57M to 2.6M | |
| 14-Feb-23 7:19 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 10-Feb-23 | Planned Option Sale | 50,000 | $10.11 | $505,605.00 | (2%) 2.62M to 2.57M | |
| 14-Feb-23 7:13 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 10-Feb-23 | Option Exercise | 50,000 | $2.50 | $125,000.00 | 2% 2.57M to 2.62M | |
| 14-Feb-23 7:13 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 10-Feb-23 | Planned Option Sale | 50,000 | $10.11 | $505,555.00 | (2%) 2.62M to 2.57M | |
| 14-Feb-23 7:19 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 10-Feb-23 | Option Exercise | 50,000 | $2.50 | $125,000.00 | 2% 2.57M to 2.62M | |
| 14-Feb-23 7:16 PM View: | Hoitt Jason Chief Commercial Officer | Provention Bio, Inc. (PRVB) | 10-Feb-23 | Private Sale (Planned) | 4,500 | $10.00 | $45,005.40 | (100%) 4.5K to 0 | |
| 20-Jan-23 8:00 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 18-Jan-23 | Option Exercise | 24,015 | $2.50 | $60,037.50 | < 1% 2.57M to 2.6M | |
| 20-Jan-23 4:10 PM View: | Sessa Capital (master), L.P. 10% Owner | Provention Bio, Inc. (PRVB) | 18-Jan-23 | Private Sale | 3,000,000 | $9.40 | $28,200,000.00 | (20%) 14.88M to 11.88M | |
| 20-Jan-23 8:00 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 18-Jan-23 | Planned Option Sale | 24,015 | $10.27 | $246,584.00 | (< 1%) 2.6M to 2.57M | |
| 20-Jan-23 8:00 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 18-Jan-23 | Option Exercise | 24,165 | $2.50 | $60,412.50 | < 1% 2.57M to 2.59M | |
| 20-Jan-23 8:00 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 18-Jan-23 | Planned Option Sale | 24,165 | $10.27 | $248,063.00 | (< 1%) 2.59M to 2.57M | |
| 30-Dec-22 4:01 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 29-Dec-22 | Option Sale | 187,000 | $10.26 | $1,918,600.00 | (7%) 2.76M to 2.57M | |
| 30-Dec-22 4:01 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 29-Dec-22 | Option Exercise | 187,000 | $2.50 | $467,500.00 | 7% 2.57M to 2.76M | |
| 29-Dec-22 4:01 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 27-Dec-22 | Option Exercise | 10,674 | $2.50 | $26,685.00 | < 1% 2.57M to 2.58M | |
| 29-Dec-22 4:01 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 27-Dec-22 | Option Sale | 10,674 | $10.00 | $106,740.00 | (< 1%) 2.58M to 2.57M | |
| 27-Dec-22 5:51 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 23-Dec-22 | Option Exercise | 375 | $2.50 | $937.50 | < 1% 2.57M to 2.57M | |
| 27-Dec-22 5:51 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 23-Dec-22 | Option Sale | 375 | $10.00 | $3,750.00 | (< 1%) 2.57M to 2.57M | |
| 27-Dec-22 5:51 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 22-Dec-22 | Option Sale | 1,568 | $10.00 | $15,681.10 | (< 1%) 2.57M to 2.57M | |
| 27-Dec-22 5:51 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 22-Dec-22 | Option Exercise | 1,568 | $2.50 | $3,920.00 | < 1% 2.57M to 2.57M | |
| 14-Feb-22 10:00 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 23-Dec-21 | Gift | 1,000,000 | -- | -- | 39% 2.57M to 3.57M | |
| 14-Feb-22 10:00 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 23-Dec-21 | Gift | 1,000,000 | -- | -- | (28%) 3.57M to 2.57M | |
| 06-Dec-21 9:28 PM View: | Ramos Eleanor Chief Medical Officer | Provention Bio, Inc. (PRVB) | 03-Dec-21 | Market Purchase | 5,201 | $6.49 | $33,764.90 | 8% 64.8K to 70.0K | (< 1%) |
| 01-Dec-21 9:21 PM View: | Palmer Ashleigh Director and CEO Director | Provention Bio, Inc. (PRVB) | 30-Nov-21 | Market Purchase | 3,750 | $6.66 | $24,990.00 | < 1% 2.57M to 2.57M | 4% |
| 29-Nov-21 5:15 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 24-Nov-21 | Market Purchase | 5,550 | $7.24 | $40,187.60 | < 1% 2.57M to 2.57M | (3%) |
| 02-Sep-20 7:43 PM View: | Ramos Eleanor Chief Medical Officer | Provention Bio, Inc. (PRVB) | 02-Sep-20 | Market Purchase | 299 | $12.06 | $3,605.94 | < 1% 64.5K to 64.8K | (37%) |
| 02-Sep-20 5:00 PM View: | Drechsler Andrew T Chief Financial Officer | Provention Bio, Inc. (PRVB) | 02-Sep-20 | Market Purchase | 2,000 | $11.72 | $23,440.00 | 11% 18.0K to 20.0K | (35%) |
| 21-Aug-20 4:05 PM View: | Leon Francisco Chief Scientific Officer | Provention Bio, Inc. (PRVB) | 21-Aug-20 | Market Purchase | 2,000 | $13.35 | $26,708.00 | < 1% 2.57M to 2.57M | (43%) |
| 20-Aug-20 6:52 PM View: | Ramos Eleanor Chief Medical Officer | Provention Bio, Inc. (PRVB) | 20-Aug-20 | Market Purchase | 2,500 | $13.23 | $33,075.00 | 4% 62.0K to 64.5K | (43%) |
| 18-Aug-20 6:10 PM View: | Palmer Ashleigh President and CEO Director | Provention Bio, Inc. (PRVB) | 18-Aug-20 | Market Purchase | 500 | $12.69 | $6,345.00 | < 1% 2.57M to 2.57M | (40%) |
| 17-Aug-20 7:20 PM View: | Palmer Ashleigh President and CEO Director | Provention Bio, Inc. (PRVB) | 17-Aug-20 | Market Purchase | 2,800 | $12.83 | $35,924.00 | < 1% 2.56M to 2.57M | (41%) |
